steverob
That was a good link you posted...timely dated today!
I liked this bit
"Although the terms were not disclosed, Pearce said the deal involves significant milestones and royalties. "We expect it should lead to revenues [to Proteome] in 2003- 2004.""
And the fact that CJP thinks it is the first commercialised deal in the field of proteomic application. So there you go PRMers, not only do you hold the best performing UK biotech of 2002, you are very well set up to repeat that for 2003!